Clinical Trials
The Phase 1a clinical trial is ongoing in the United Kingdom.
For additional information on current and future clinical studies, please consult your physician.
Trial Name
CV6-168
A first in human study to investigate the safety and tolerability of CV6-168 in combination with anti-cancer treatments in patients with advanced cancer.
Status
Active
phase
Phase 1a
Discovery
Preclinical
Phase 1a
Phase 1b
Disclaimer: CV6-168 and CV6-1271 are investigational therapies that have not been approved for use outside clinical studies by the MHRA, FDA, or other regulatory authorities.
“”
